NLRP3 and Hyperglycemia: A similar behavior was seen in cardiomyocytes: hyperglycemia increased expression of NLRP3 and MyD88 in a way that is sensitive to empagliflozin or shifting from high glucose to low glucose (Figure 6C,F).